Żelazny, P. (2022) “Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF)”, Journal of Education, Health and Sport, 12(9), pp. 583–588. doi: 10.12775/JEHS.2022.12.09.068.